Skip to content
  • About
  • Shop
  • News
  • Contact Us
Search
NECA Logo
  • NET Nurse
  • Donate
  • What are NETs?
    • What are Neuroendocrine Cancers?
    • What are Pheos & Paras?
    • NET Symptoms
    • NET Types
    • Causes
    • Treatments
    • Grades
    • Diagnosis
    • Prognosis
    Consider the Grey Area
  • Patients & Carers
    • Patient & Carer Support
    • Patient Resources
    • Optimal Care Pathway
    • NET Nurse
    • Patient Stories
    • Share your Story
    • Australian NET Specialists
    • Clinical Trials
    • Living with NETS
    • Specialist Support Services
    Consider the Grey Area
  • Healthcare Professionals
    • Optimal Care Pathway
    • Professional Learning
    • Patient Referral
    • Clinical Trials
    • NET Symptoms
    • Australian NET Specialists
    • Request an In-Service
    • PLANET Registry
    • Order Booklets & Resources
    Consider the Grey Area
  • Get Involved
    • Advocate for Us
    • Share your Story
    • Donate
    • Fundraise
    • Events
    • In Memoriam
    • Corporate Partners
    • Gifts & Wills
    • Volunteer
    Senate MailChimp
  • March4NETs
NET Nurse
Donate

Home » Unexplained Weight Loss in NETs Patients

Unexplained Weight Loss in NETs Patients

Neuroendocrine tumours (NETs) represent a diverse group of neoplasms that originate from neuroendocrine cells distributed throughout the body. These tumours can be benign or malignant and are often characterised by their ability to produce hormones and other bioactive substances. 

Among the myriad of symptoms and complications associated with NETs, unexplained weight loss is particularly troubling, as it can significantly impact a patient’s quality of life and overall prognosis. 

This article examines unexplained weight loss in NETs patients, explores the potential causes, and discusses effective strategies for diagnosis and management.

Neuroendocrine Cancer Australia (NECA), is dedicated to assisting individuals with neuroendocrine cancer and their families. NECA offers a wealth of resources, educational programs, and advocacy efforts aimed at deepening the understanding of NETs, improving patient care, and encouraging research advancements. Patients diagnosed with NETs can engage with NECA’s comprehensive support and information by calling the NET nurse line.

Importance of addressing unexplained weight loss in NETs patients

Unexplained weight loss in patients with neuroendocrine tumours is more than just a symptom; it is a clinical challenge that can have profound implications for patient health. Weight loss can lead to malnutrition, decreased muscle strength, increased susceptibility to infections, and a diminished ability to tolerate treatments. 

Addressing this issue promptly is crucial not only for improving the patient’s quality of life but also for optimising treatment outcomes and potentially enhancing survival rates. For healthcare providers, recognising and addressing unexplained weight loss early can lead to better patient management and care.

Understanding neuroendocrine tumours (NETs)

NETs arise from cells of the neuroendocrine system, which have characteristics of both nerve cells and hormone-producing cells. These tumours can occur in various parts of the body, including the gastrointestinal tract, pancreas, and lungs. NETs are known for their diverse clinical manifestations, primarily due to their potential to secrete a variety of hormones, leading to complex syndromes and symptoms.

Symptoms and clinical manifestations of NETs

The clinical presentation of NETs varies widely depending on the tumour’s location, size, and hormonal activity. 

Common symptoms include:

  • Flushing
  • Diarrhoea
  • Abdominal pain
  • Wheezing
  • Unexplained weight loss. 

The hormonal activity of NETs can cause specific syndromes, such as carcinoid syndrome, which is characterised by flushing and diarrhoea, and insulinoma syndrome, which leads to hypoglycemia and associated symptoms. These varied presentations often result in a delay in diagnosis, as they can mimic more common conditions.

Causes of unexplained weight loss in NET patients

There are a range of causes of unexplained weight loss for NET patients. Keep in mind that this is not a totally exhaustive list, and depending on the tumour location and stage, that weight loss may be attributed to other factors.

1. Tumour metabolism and energy expenditure

One of the primary causes of unexplained weight loss in NET patients is the altered metabolism induced by the tumours. NETs can create a hypermetabolic state by increasing the body’s energy expenditure. 

The tumours themselves can consume a significant amount of energy, leading to an overall increase in the metabolic rate. This hypermetabolic state can result in significant weight loss, even if the patient maintains an adequate caloric intake.

2. Hormonal secretion by NETs

Many NETs secrete hormones or hormone-like substances that can profoundly impact metabolism and appetite. For instance, serotonin-secreting tumours (neuroendocrine tumours) can cause carcinoid syndrome, characterised by diarrhoea and subsequent weight loss. 

3. Gastrointestinal complications

NETs often affect the gastrointestinal (GI) tract, leading to various complications that contribute to weight loss. Tumours in the GI tract can cause mechanical obstruction, malabsorption, and chronic diarrhoea, all of which can result in significant nutrient loss and weight reduction. 

Additionally, surgeries or treatments aimed at managing these tumours can further impact GI function, exacerbating weight loss.

Diagnosis and evaluation of weight loss in NET patients

Evaluating unexplained weight loss in NETs patients requires a comprehensive approach. Clinicians should take a detailed medical history, including:

  • Dietary habits
  • Weight history
  • Symptoms
  • Physical examination

This approach helps identify potential causes of weight loss and related symptoms, guiding further diagnostic testing.

Diagnostic tests and imaging

A variety of diagnostic tests and imaging studies are essential for diagnosing NETs and understanding the extent of the disease. Blood tests for hormone levels can help identify functional tumours, while imaging studies such as CT scans, MRI, and PET scans are crucial for locating tumours and assessing their spread. Endoscopic procedures may also be necessary to visualise the GI tract and obtain biopsy samples, providing histological confirmation of NETs.

Importance of nutritional assessment

Nutritional assessment is a critical component in the evaluation of unexplained weight loss in NETs patients. This assessment includes evaluating dietary intake, calculating body mass index (BMI), and conducting laboratory tests to assess for nutritional deficiencies. The involvement of a dietitian is often beneficial, as they can develop and monitor a tailored nutrition plan aimed at addressing weight loss and improving overall health.

Management of unexplained weight loss

Fortunately, there are ways to manage unexplained weight loss for NET patients. These strategies should always be undertaken after instruction from a dietician, GP, oncologist, or related member of your healthcare team.

Medical interventions

The primary goal of medical management for weight loss in NETs patients is to treat the underlying tumour and associated symptoms. Surgical removal of the tumour, when feasible, can alleviate symptoms and potentially allow for weight gain. 

For patients who are not candidates for surgery, other treatments such as chemotherapy, targeted therapy, or peptide receptor radionuclide therapy (PRRT) may be used to control tumour growth and hormonal secretion. These treatments can help stabilise the patient’s condition and mitigate weight loss.

Nutritional support and dietary modifications

Nutritional support is a cornerstone of managing unexplained weight loss in NETs patients. This can include high-calorie and high-protein diets to meet the increased metabolic demands. Oral nutritional supplements may be necessary to ensure adequate nutrient intake. 

In severe cases, enteral nutrition (tube feeding) or parenteral nutrition (intravenous feeding) may be required. Dietitians play a crucial role in developing these nutritional plans, monitoring the patient’s progress, and making necessary adjustments to optimise their nutritional status.

Medications to stimulate appetite

In some cases, medications may be prescribed to stimulate appetite and promote weight gain. The use of medication Creon to assist with pancreatic enzyme supplements to help with digestion and absorbing food. However, the use of these medications should be carefully monitored due to potential side effects, including fluid retention and an increased risk of infection.

Weight loss and the impact on quality of life

Weight loss and other bodily changes can significantly impact a patient’s quality of life. Here are some things to be aware of when moving through NET treatment.

Physical and emotional effects of weight loss

Unexplained weight loss can have profound physical and emotional effects on NETs patients. Physically, it can lead to weakness, fatigue, and decreased ability to tolerate cancer treatments. This, in turn, can result in a diminished quality of life and reduced functional status. 

Emotionally, the stress and anxiety associated with significant weight loss can exacerbate feelings of distress, depression, and hopelessness, further impacting the patient’s overall wellbeing.

Coping strategies for patients and families

Patients with NETs experiencing weight loss can benefit from various coping strategies. Support groups provide a platform for sharing experiences and receiving emotional support from others facing similar challenges. Psychological counselling can help patients manage anxiety and depression associated with their condition. 

Additionally, engaging in physical activity where possible can improve overall strength, mood, and wellbeing. Educating patients and their families about the nature of the disease and the importance of nutrition can empower them to take an active role in managing their health.

Research and future directions

Research on unexplained weight loss in NETs patients is ongoing, with studies focusing on understanding the underlying mechanisms and developing effective management strategies. Clinical trials are exploring new therapies and interventions aimed at addressing weight loss and improving patient outcomes. These studies are crucial for advancing our understanding of NETs and their impact on metabolism, paving the way for more effective treatments.

Key takeaways

Unexplained weight loss in NETs patients is a complex issue that requires a comprehensive approach to diagnosis and management. Understanding the causes, performing thorough evaluations, and implementing targeted interventions are essential steps in addressing this symptom. Effective management includes treating the underlying tumour, providing nutritional support, and addressing the physical and emotional impacts of weight loss.

Comprehensive care and early intervention

Early intervention and a multidisciplinary approach are crucial for managing unexplained weight loss in NETs patients. By providing comprehensive care that includes medical, nutritional, and psychological support, healthcare providers can significantly improve the quality of life and outcomes for patients with neuroendocrine tumours. 

Neuroendocrine Cancer Australia (NECA) remains committed to supporting patients with NETs and their families. Through educational programs, advocacy efforts, and the NET nurse line, NECA provides valuable resources and guidance to help patients navigate their journey with NETs. Early and comprehensive care can make a profound difference in the lives of those affected by this challenging condition.

Further information and support for people diagnosed with NETs is available by calling the NECA NET nurse line.

Support Australians facing neuroendocrine cancer

Subscribe to Newsletter

NECA Logo
registered charity badge

What are NETs

  • About Us
  • Our People
  • Our Ambassadors
  • Consumer Advisory Group
  • International Advisory Panel
  • Governance & Policies
  • About Us
  • Our People
  • Our Ambassadors
  • Consumer Advisory Group
  • International Advisory Panel
  • Governance & Policies

Patients & Carers

  • What are Neuroendocrine Cancers?​
  • Pheos and Paras
  • NET Library
  • What are Neuroendocrine Cancers?​
  • Pheos and Paras
  • NET Library

Healthcare Professionals

  • Patient resources
  • NET Nurse
  • Patient Stories
  • Australian NET Specialists
  • Current Open Clinical Trials
  • Patient resources
  • NET Nurse
  • Patient Stories
  • Australian NET Specialists
  • Current Open Clinical Trials

Get Involved

  • Shop
  • Donate
  • Volunteer
  • Current Fundraising Campaigns
  • Fundraise
  • Shop
  • Donate
  • Volunteer
  • Current Fundraising Campaigns
  • Fundraise
All charity donations to NeuroEndocrine Cancer Australia may be tax-deductible in Australia.

Registered Charity CFN 202607
© 2025 NeuroEndocrine Cancer Australia
  • Website by Five Creative
Twitter Facebook Youtube Instagram Linkedin